The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.
Open Access
- 15 October 1996
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 15 (20) , 5557-5566
- https://doi.org/10.1002/j.1460-2075.1996.tb00940.x
Abstract
The elongin (SIII) complex strongly stimulates the rate of elongation by RNA polymerase II by suppressing transient pausing by polymerase at many sites along the DNA. Elongin (SIII) is composed of a transcriptionally active A subunit and two small regulatory B and C subunits, which bind stably to each other to form a binary complex that interacts with elongin A and strongly induces its transcriptional activity. The elongin (SIII) complex is a potential target for negative regulation by the von Hippel‐Lindau (VHL) tumor suppressor protein, which is capable of binding stably to the elongin BC complex and preventing it from activating elongin A. Here, we identify an elongin A domain sufficient for activation of elongation and demonstrate that it is a novel type of inducible activator that targets the RNA polymerase II elongation complex and is evolutionarily conserved in species as distantly related as Caenorhabditis elegans and man. In addition, we demonstrate that both the elongin A elongation activation domain and the VHL tumor suppressor protein interact with the elongin BC complex through a conserved elongin BC binding site motif that is essential for induction of elongin A activity by elongin BC and for tumor suppression by the VHL protein.Keywords
This publication has 50 references indexed in Scilit:
- A human cDNA encoding the 110-kDa A subunit of RNA polymerase II transcription factor elonginGene, 1996
- Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.Genes & Development, 1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Transcriptional elongation by RNA polymerase II is stimulated by transactivatorsCell, 1994
- GENERAL INITIATION FACTORS FOR RNA POLYMERASE IIAnnual Review of Biochemistry, 1993
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Structure and functional properties of human general transcription factor IIENature, 1991
- An RNA Polymerase II Transcription Factor Shares Functional Properties with Escherichia coli σ 70Science, 1990
- Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteinsJournal of Molecular Biology, 1978
- Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteinsBiochemistry, 1974